Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Do Hedge Funds Love Tenaris S.A. (TS)?

Is Tenaris S.A. (NYSE:TS) a good equity to bet on right now? We like to check what the smart money thinks first before doing extensive research. Although there have been several high profile failed hedge fund picks, the consensus picks among hedge fund investors have historically outperformed the market after adjusting for known risk attributes. It’s not surprising given that hedge funds have access to better information and more resources to find the latest market-moving information.

Is Tenaris S.A. (NYSE:TS) an exceptional investment today? The smart money is selling. The number of bullish hedge fund bets retreated by 2 lately. Our calculations also showed that ts isn’t among the 30 most popular stocks among hedge funds.

Hedge funds’ reputation as shrewd investors has been tarnished in the last decade as their hedged returns couldn’t keep up with the unhedged returns of the market indices. Our research has shown that hedge funds’ large-cap stock picks indeed failed to beat the market between 1999 and 2016. However, we were able to identify in advance a select group of hedge fund holdings that outperformed the market by 18 percentage points since May 2014 through December 3, 2018 (see the details here). We were also able to identify in advance a select group of hedge fund holdings that’ll significantly underperform the market. We have been tracking and sharing the list of these stocks since February 2017 and they lost 24% through December 3, 2018. That’s why we believe hedge fund sentiment is an extremely useful indicator that investors should pay attention to.

Andreas Halvorsen

Let’s take a look at the latest hedge fund action regarding Tenaris S.A. (NYSE:TS).

What have hedge funds been doing with Tenaris S.A. (NYSE:TS)?

At the end of the third quarter, a total of 18 of the hedge funds tracked by Insider Monkey were bullish on this stock, a change of -10% from one quarter earlier. The graph below displays the number of hedge funds with bullish position in TS over the last 13 quarters. With hedge funds’ capital changing hands, there exists a few noteworthy hedge fund managers who were adding to their holdings meaningfully (or already accumulated large positions).

No of Hedge Funds with TS Positions

Of the funds tracked by Insider Monkey, John Armitage’s Egerton Capital Limited has the most valuable position in Tenaris S.A. (NYSE:TS), worth close to $308.9 million, comprising 2.3% of its total 13F portfolio. Coming in second is Millennium Management, managed by Israel Englander, which holds a $85.4 million position; 0.1% of its 13F portfolio is allocated to the company. Remaining peers that are bullish comprise Ken Griffin’s Citadel Investment Group, Andreas Halvorsen’s Viking Global and John W. Rogers’s Ariel Investments.

Judging by the fact that Tenaris S.A. (NYSE:TS) has experienced bearish sentiment from hedge fund managers, it’s safe to say that there were a few money managers that slashed their positions entirely last quarter. Interestingly, Todd J. Kantor’s Encompass Capital Advisors sold off the biggest investment of the “upper crust” of funds monitored by Insider Monkey, comprising about $25.5 million in stock, and Jim Simons’s Renaissance Technologies was right behind this move, as the fund dropped about $24.7 million worth. These moves are intriguing to say the least, as aggregate hedge fund interest dropped by 2 funds last quarter.

Let’s check out hedge fund activity in other stocks similar to Tenaris S.A. (NYSE:TS). We will take a look at Regions Financial Corporation (NYSE:RF), TransDigm Group Incorporated (NYSE:TDG), Verisign, Inc. (NASDAQ:VRSN), and Expedia Group, Inc. (NASDAQ:EXPE). This group of stocks’ market valuations match TS’s market valuation.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
RF 31 951749 -10
TDG 48 3883567 7
VRSN 29 4820588 4
EXPE 37 3118988 -1
Average 36.25 3193723 0

View table here if you experience formatting issues.

As you can see these stocks had an average of 36.25 hedge funds with bullish positions and the average amount invested in these stocks was $3.19 billion. That figure was $687 million in TS’s case. TransDigm Group Incorporated (NYSE:TDG) is the most popular stock in this table. On the other hand Verisign, Inc. (NASDAQ:VRSN) is the least popular one with only 29 bullish hedge fund positions. Compared to these stocks Tenaris S.A. (NYSE:TS) is even less popular than VRSN. Considering that hedge funds aren’t fond of this stock in relation to other companies analyzed in this article, it may be a good idea to analyze it in detail and understand why the smart money isn’t behind this stock. This isn’t necessarily bad news. Although it is possible that hedge funds may think the stock is overpriced and view the stock as a short candidate, they may not be very familiar with the bullish thesis. In either case more research is warranted.

Disclosure: None. This article was originally published at Insider Monkey.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading...